| Application no. and date | 05788521.2 (espacenet) (Federated) (European Patent Register), 20050930 | | Patent/reg. no. and date | DK/EP 1802274, 20080917 | | Publication date | 20070704 | | Priority no. and date | GB 0421900, 20041001 | | EP pub. no. and date |
EP 1802274 20070704 | | Effective date | | | Applicant/owner | GW Pharma Limited, Porton Down Science Park
Salisbury,
Wiltshire SP4 OJQ, GB | | Applicant ref. no. | 6.0809.007 | | Inventor | Whittle, Brian, Porton Down Science Park
Salisbury,
Wiltshire SP4 0JQ, GB,
Parolaro, Daniela,
DBSF, Pharm. Section, Center of Neuroscience,
Via A. da Giussano 10
21052 Busto Arsizio (VA), IT | | Representative | Holme Patent A/S, Valbygårdsvej 33, 1, 2500 Valby, DK | | Opponent | | | IPC Class | A61K 36/18 (2006.01) , A61P 35/04 (2006.01) | | Title | Anvendelse af cannabidiol i inhibitionen af hjernetumorcellemigration | | Int. application no. | GB2005003793 | | Int. publication no. | WO2006037981 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
